Pneumocystis jirovecii pneumonia: a rare but serious complication during TNF inhibitor treatment for rheumatoid arthritis in Japan

Author： Miyasaka Nobuyuki   Harigai Masayoshi  

Publisher： Future Medicine

ISSN： 1758-4272

Source： International Journal of Clinical Rheumatology, Vol.8, Iss.4, 2013-08, pp. : 425-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Changes in chemokines and their receptors in blood during treatment with the TNF inhibitor infliximab in patients with rheumatoid arthritis

By Eriksson C   Rantapää-Dahlqvist S   Sundqvist KG  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 4, 2013-08 ,pp. : 260-265

Informa Healthcare

Access to resources Recommend Favorite

Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients

By Watanabe Kaori   Sakai Ryoko   Koike Ryuji   Sakai Fumikazu   Sugiyama Haruhito   Tanaka Michi   Komano Yukiko   Akiyama Yuji   Mimura Toshihide   Kaneko Motohide   Tokuda Hitoshi   Iso Takenobu   Motegi Mitsuru   Ikeda Kei   Nakajima Hiroshi   Taki Hirofumi   Kubota Tetsuo   Kodama Hirotaka   Sugii Shoji   Kuroiwa Takashi   Nawata Yasushi   Shiozawa Kazuko   Ogata Atsushi   Sawada Shigemasa   Matsukawa Yoshihiro   Okazaki Takahiro   Mukai Masaya   Iwahashi Mitsuhiro   Saito Kazuyoshi   Tanaka Yoshiya   Nanki Toshihiro   Miyasaka Nobuyuki   Harigai Masayoshi  

Modern Rheumatology, Vol. 23, Iss. 6, 2013-11 ,pp. : 1085-1093

Springer Publishing Company

Access to resources Recommend Favorite

Plasma TNF binding capacity profiles during treatment with etanercept in rheumatoid arthritis

By Gudbrandsdottir S   Bliddal H   Petri A   Terslev L   Danneskiold-Samsoe B   Bjørnhart B   Bendtzen K   Müller K  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 6, 2004-11 ,pp. : 385-388

Informa Healthcare

Access to resources Recommend Favorite

Aspects of TNF inhibitor therapy in rheumatoid arthritis

By Nam Jackie   Emery Paul  

Modern Rheumatology, Vol. 20, Iss. 4, 2010-08 ,pp. : 325-330

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of the Selective Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Rheumatoid Arthritis and Osteoarthritis in Japan

By  

Digestion, Vol. 83, Iss. 1-2, 2010-11 ,pp. : 108-123

Karger

Access to resources Recommend Favorite